{"id":"W2165290386","doi":"10.1016/s0140-6736(14)60661-9","title":"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":453,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Western University","funders":"Genentech; Wellcome Trust","keywords":"Ulcerative colitis; Medicine; Induction therapy; Internal medicine; Gastroenterology; Colitis; Randomized controlled trial; Chemotherapy; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003044157,0.001744817,0.003355782,0.0004532838,0.0004047661,0.001241269,0.001090905,0.002823257,0.009962308],"category_scores_gemma":[0.002687877,0.0007291725,0.001992582,0.0004780208,0.00118332,0.001214729,0.000496898,0.003008466,0.001246562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000814589,"about_ca_system_score_gemma":0.001270374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006556532,"about_ca_topic_score_gemma":0.001477945,"domain_scores_codex":[0.9988878,0.0006517536,0.00007290462,0.0001663021,0.00008123563,0.0001400174],"domain_scores_gemma":[0.9988417,0.000362417,0.0003231525,0.00009375626,0.00008174767,0.0002972093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9836406,0.003338137,0.0002864615,0.00117353,0.0005230216,0.00005060909,0.00004108647,0.0001614665,0.001270005,0.0000981283,0.001009347,0.008407644],"study_design_scores_gemma":[0.985494,0.01346289,0.0003492794,0.00003275643,0.0001285491,0.0000181732,0.000005558716,0.00007447621,0.00005775463,0.00003679737,0.0003355198,0.000004230389],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9397066,0.0239627,0.001663336,0.00327676,0.002335532,0.01943483,0.003986997,0.000338646,0.005294602],"genre_scores_gemma":[0.9323111,0.01363246,0.004166532,0.004764077,0.002068789,0.02826952,0.00365249,0.00005750136,0.0110776],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009962308,"threshold_uncertainty_score":0.03332728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01873240076144263,"score_gpt":0.3030819825346319,"score_spread":0.2843495817731893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}